{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":23,"n_cols":5,"rows_kept":23,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[9,2,9,3],[17,2,17,3],[18,2,18,3],[21,2,21,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910407732503321"]
[null,null,"Titolo",null,"Molecular Imaging in Oncology / / edited by Otmar Schober, Fabian Kiessling, Jürgen Debus"]
[null,null,"Pubbl/distr/stampa",null,"Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020"]
[null,null,"ISBN",null,"3-030-42618-1"]
[null,null,"Edizione",null,"[2nd ed. 2020.]"]
[null,null,"Descrizione fisica",null,"1 online resource (911 pages)"]
[null,null,"Collana",null,"Recent Results in Cancer Research, , 2197-6767 ; ; 216"]
[null,null,"Disciplina",null,"616.0756"]
[{"$nulls":4},"616.9940754"]
[null,null,"Soggetti",null,"Oncology"]
[{"$nulls":4},"Radiology"]
[{"$nulls":4},"Nuclear medicine"]
[{"$nulls":4},"Nuclear Medicine"]
[{"$nulls":4},"Oncologia"]
[{"$nulls":4},"Medicina nuclear"]
[{"$nulls":4},"Diagnòstic radiològic"]
[{"$nulls":4},"Llibres electrònics"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Nota di bibliografia","Includes bibliographical references."]
[null,null,"Nota di contenuto",null,"Computed tomography and magnetic resonance imaging -- Single photon emission computed tomography – tracer -- Non-peptidyl 18F-labelled PET tracers as radioindicators for the noninvasive detection of cancer -- Ultrasound Imaging -- Optical and opto-acoustic imaging -- Multifunctional magnetic imaging probes -- Modern X-ray concepts-differential phase-contrast imaging -- Pre-clinical SPECT and SPECT-CT -- Optical and photo-acoustic imaging -- Applications of small animal PET -- Preclinical molecular imaging using PET and MRI -- Molecular ultrasound imaging -- Advanced microscopy techniques -- Mass spectroscopy -- Quantitative SPECT-CT -- Optical imaging of breast tumors and of gastrointestinal cancer by laser-induced fluorescence -- FDG PET and PET-CT -- Non-FDG PET-CT -- Clinical MR biomarkers -- Clinical PET-MR -- Advanced ultrasound imaging -- Radiomics and Radiogenomics -- Cross validation techniques -- Image-guided brain surgery -- Image-guided abdominal surgery -- Photon radiation therapy -- Particle radiation therapy -- Internal radiotherapy -- Future challenges of multimodality imaging."]
[null,null,null,"Sommario/riassunto","This book discusses the most significant recent advances in oncological molecular imaging, covering the full spectrum from basic and preclinical research to clinical practice. The content is divided into five sections, the first of which is devoted to standardized and emerging technologies and probe designs for different modalities, such as PET, SPECT, optical and optoacoustic imaging, ultrasound, CT, and MRI. The second section focuses on multiscale preclinical applications ranging from advanced microscopy and mass spectroscopy to whole-body imaging. In the third section, various clinical applications are presented, including image-guided surgery and the radiomic analysis of multiple imaging features. The final two sections are dedicated to the emerging, crucial role that molecular imaging can play in the planning and monitoring of external and internal radiotherapy, and to future challenges and prospects in multimodality imaging. Given its scope, the handbook will benefit all readers who are interested in the revolution in diagnostic and therapeutic oncology that is now being brought about by molecular imaging."]